Time to resolution · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure requiring exchange transfusionc,d · infants with confirmed hyperbilirubinemia
Sunlight (with or without filters or amplification) showed no clear difference in treatment failure requiring exchange transfusionc,d compared with other sources of phototherapy (low certainty).
1 finding from 1 review
Acute bilirubin encephalopathy · infants with confirmed hyperbilirubinemia
Sunlight (with or without filters or amplification) may leads to lower acute bilirubin encephalopathyc,f compared with other sources of phototherapy (low certainty).
1 finding from 1 review
Deathc · infants with confirmed hyperbilirubinemia
Sunlight (with or without filters or amplification) may leads to lower deathc compared with other sources of phototherapy (low certainty).
1 finding from 1 review
Proportion of days of effective treatmenti · infants with confirmed hyperbilirubinemia
It is very uncertain whether sunlight (with or without filters or amplification) changes proportion of days of effective treatmenti compared with other sources of phototherapy (very low certainty).
1 finding from 1 review
Outcomesa · infants with confirmed hyperbilirubinemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment success as defined by the authors · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain frequency or change in frequency · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain intensity or change in intensity · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with inflammatory bowel disease
1 finding from 1 review
Clinical score · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Topical triamcinolone acetonide may leads to higher clinical score compared with photodynamic therapy (low certainty).
1 finding from 1 review
Clinical resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
1 finding from 1 review
Pain (mean score, split-mouth) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical triamcinolone acetonide changes pain (mean score, split-mouth) compared with cryotherapy (very low certainty).
1 finding from 1 review
Death (all causes) · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in death (median compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Kidney function · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dialysis · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in dialysis (median compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Relapse · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in relapse at 18 months compared with cyclophosphamide (moderate certainty).
2 findings from 1 review
Serious adverse events · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in serious adverse events compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Infections · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in infections compared with cyclophosphamide (moderate certainty).
1 finding from 1 review